Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;330:267-268 (5 February), doi:10.1136/bmj.330.7486.267
Are clear for severe depression, but uncertain for mild or moderate depression
| The first 150 words of the full text of this article appear below. |
Guidelines from the National Institute for Clinical Excellence (NICE) focus on clinical conditions that have a substantial impact on public health and aim to improve standards of care and reduce variations in provision. Depression is a common condition, contributing 12% of the total burden of nonfatal global disease.1 Variations in its treatment within the NHS are striking and perplexing.2 3 We welcome these guidelines and recent advice from the Medicines and Healthcare products Regulatory Agency (MHRA) concerning the prescription of antidepressants.4 5
The methods underpinning the guidelines were rigorous and produced a definitive summary of current evidence. However, the uncertainty of many recommendations is disappointing. The guidelines advocate a stepped care approach, but the weakness of evidence supporting structured interventions for mild to moderate depression limits the value of recommendations referring to initial steps.
The review of the evidence highlights associations between the severity of depression and response to antidepressant medication.
Hugh Middleton, senior lecturer
Division of Psychiatry, University of Nottingham, Nottingham NG3 6AA
Ian Shaw, professor of health policy, Sally Hull, clinical senior lecturer
School of Sociology and Social Policy, University of Nottingham, Nottingham NG7 2RD
Gene Feder, professor of primary care research and development
Barts and the London, Queen Mary's School of Medicine and Dentistry, London E14NS (g.s.feder@qmul.ac.uk)
Read all Rapid Responses